Shockwave Medical Inc (DELISTED) (SWAV:DL)
334.75
-0.08
(-0.02%)
USD |
NASDAQ |
May 30, 16:00
Shockwave Medical Enterprise Value: 12.27B for May 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 30, 2024 | 12.27B |
May 29, 2024 | 12.27B |
May 28, 2024 | 12.26B |
May 24, 2024 | 12.25B |
May 23, 2024 | 12.25B |
May 22, 2024 | 12.24B |
May 21, 2024 | 12.08B |
May 20, 2024 | 12.09B |
May 17, 2024 | 12.10B |
May 16, 2024 | 12.13B |
May 15, 2024 | 12.13B |
May 14, 2024 | 12.13B |
May 13, 2024 | 12.11B |
May 10, 2024 | 12.11B |
May 09, 2024 | 12.11B |
May 08, 2024 | 12.12B |
May 07, 2024 | 12.11B |
May 06, 2024 | 12.09B |
May 03, 2024 | 12.11B |
May 02, 2024 | 12.09B |
May 01, 2024 | 12.09B |
April 30, 2024 | 12.09B |
April 29, 2024 | 12.06B |
April 26, 2024 | 12.08B |
April 25, 2024 | 12.04B |
Date | Value |
---|---|
April 24, 2024 | 12.04B |
April 23, 2024 | 12.03B |
April 22, 2024 | 12.03B |
April 19, 2024 | 12.04B |
April 18, 2024 | 11.99B |
April 17, 2024 | 11.99B |
April 16, 2024 | 11.99B |
April 15, 2024 | 11.97B |
April 12, 2024 | 11.99B |
April 11, 2024 | 12.01B |
April 10, 2024 | 12.07B |
April 09, 2024 | 11.98B |
April 08, 2024 | 11.92B |
April 05, 2024 | 11.94B |
April 04, 2024 | 11.71B |
April 03, 2024 | 11.73B |
April 02, 2024 | 11.70B |
April 01, 2024 | 11.73B |
March 31, 2024 | 11.92B |
March 28, 2024 | 11.92B |
March 27, 2024 | 11.81B |
March 26, 2024 | 11.56B |
March 25, 2024 | 10.48B |
March 22, 2024 | 10.25B |
March 21, 2024 | 10.41B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
554.16M
Minimum
Mar 20 2020
12.27B
Maximum
May 29 2024
5.619B
Average
6.197B
Median
Enterprise Value Benchmarks
Boston Scientific Corp | 121.07B |
Masimo Corp | 6.747B |
Tactile Systems Technology Inc | 222.35M |
RxSight Inc | 1.996B |
Perspective Therapeutics Inc | 528.24M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 55.35M |
Revenue (Quarterly) | 218.80M |
Total Expenses (Quarterly) | 176.40M |
EPS Diluted (Quarterly) | 1.44 |
Gross Profit Margin (Quarterly) | 87.11% |
Profit Margin (Quarterly) | 25.29% |
Earnings Yield | 1.28% |
Operating Earnings Yield | 1.26% |
Normalized Earnings Yield | 1.279 |